FIELD: biotechnology, immunology.
SUBSTANCE: a mosaic recombinant polypeptide containing fragments of the hepatitis E virus proteins ORF2 and ORF3 of genotypes 1 and 3 in one polypeptide chain is described. The product is designed for use in test systems used in the serodiagnosis of hepatitis E.
EFFECT: genetic engineering design containing fragments of the orf2 and orf3 genes of HEV 1 and 3 genotypes in one reading frame; the strain is a producer of a mosaic recombinant polypeptide with fragments of the ORF2 and ORF3 proteins of the HEV 1 and 3 genotypes as part of one polypeptide chain; a purified mosaic recombinant polypeptide with fragments of the ORF2 and ORF3 proteins of the HEV 1 and 3 genotypes as part of one polypeptide chain.
1 cl, 30 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT PROTEIN CONTAINING ANTIGEN-SIGNIFICANT FRAGMENTS OF HEPATITIS E VIRUS PROTEINS, USED IN TEST SYSTEMS FOR HEPATITIS E SERODIAGNOSIS (EMBODIMENTS) | 2017 |
|
RU2711907C2 |
METHOD OF SYNTHESIS OF POLYPEPTIDE ELICITING ANTIGENIC ACTIVITY OF HEPATITIS E VIRUS AND SET FOR ASSAY OF ANTIBODY RAISED TO HEPATITIS E PATHOGEN | 1998 |
|
RU2172346C2 |
SET FOR ASSAY OF ANTIBODY TO THE HUMAN HEPATITIS C VIRUS (VARIANTS) | 1993 |
|
RU2084527C1 |
RECOMBINANT VACCINE FOR PREVENTION OF VIRAL HEPATITIS E IN ANIMALS | 2012 |
|
RU2501568C1 |
METHOD FOR OBTAINING RECOMBINANT CORE PROTEIN OF HEPATITIS E VIRUS AND RECOMBINANT VACCINE FOR PROPHYLAXIS OF HEPATITIS E VIRUS | 2012 |
|
RU2501809C1 |
METHOD OF PRODUCING RECOMBINANT CAPSID PROTEIN OF HEPATITIS E VIRUS | 2016 |
|
RU2745558C2 |
METHOD FOR ASSESSING ANTIBODY LEVEL SPECIFIC TO DIFFERENT VARIANTS OF HEPATITIS B VIRUS HBsAg | 2016 |
|
RU2616236C1 |
IMMUNOGENIC COMPOSITION CONTAINING CHIMERIC HIV POLYPEPTIDE, POLYPEPTIDES AND TEST-SYSTEM FOR DETECTION OF ANTIBODIES RAISED TO HIV | 2001 |
|
RU2214274C2 |
RECOMBINANT PROTEINS CONTAINING ANTIGENIC EPITOPES OF PROTEINS CORE, SMALL ENVELOPE, NS2A AND PREM OF ZIKA VIRUS, AND COMPLEX ANTIGEN CONTAINING SPECIFIED PROTEINS WHICH ARE USED AS A COMPONENT OF THE IMMUNOENZYMOMETRIC TEST SYSTEM FOR THE IDENTIFICATION OF ANTIBODIES CLASSES G AND M TO ZIKA VIRUS | 2017 |
|
RU2661085C1 |
VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
Authors
Dates
2021-09-07—Published
2020-11-30—Filed